Blood Cells, Molecules, and Diseases

Aims & Scope

BCMD is interested in contributions in basic, translational and clinical research focusing on the biology of blood cells and the pathophysiology of blood disorders, with a specific interest in non-malignant conditions.

We will consider studies on hematological malignancies when secondary to inherited or acquired bone marrow failure or disorders of the immune system.

Research Areas include: Erythropoiesis, Erythrocyte Biology, Hemoglobin and its disorders Myelopoiesis, myeloid cells and disorders of the myeloid lineage (incl. myeloproliferative disorders) Megakaryopoiesis and platelet disorders Hemostasis & Thrombosis and disorders of coagulation Transfusion medicine and the study of therapeutic blood products (including novel biotechnologies related to transfusion products) Bone marrow failure (severe aplastic anemia, myelodysplasia, etc.) Immunodeficiency and dysregulation of the immune system Auto-immune disorders relating to blood

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	1.7
2024	2.10

Journal Rank

Year	Value
2024	9116

Journal Citation Indicator

Year	Value
2024	251

SJR (SCImago Journal Rank)

Year	Value
2024	0.633

Quartile

Year	Value
2024	Q2

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• The global prevalence of glucose-6-phosphate dehydrogenase deficiency: A systematic review and meta-analysis

  Citation: 537

  Authors: Ella T., Charles, Vani, Susan A., Ernest

• Tumor exosomes expressing Fas ligand mediate CD8+ T-cell apoptosis

  Citation: 362

  Authors: Ashraf J., Zhaohui, Xiufen, Mu, Thomas E., Joseph L., Wei-Ping

• Mutation Analysis in Hereditary Hemochromatosis

  Citation: 308

  Authors: Ernest, Terri, Carol, Pauline, Michele, Ryan, Paul, Michael, Charles P., Pradyumna D., Nicole K., Karen A., Amy E., Glenn S., Michael

• The ferroportin disease

  Citation: 307

  Authors: A

• Understanding the biology of angiogenesis: Review of the most important molecular mechanisms

  Citation: 295

  Authors: Z, R, J, A

• Genetic and Physical Mapping of theLpsLocus: Identification of the Toll-4 Receptor as a Candidate Gene in the Critical Region

  Citation: 293

  Authors: Alexander, Irina, Xiaolong, Mu-Ya, Christophe, Dale, Erica, Maria, Xin, Patricia, Edward K.L., Jessica, Bruce, Sandra, Stefanie N., Bruce

• Vascular endothelial growth factor family of ligands and receptors: Review

  Citation: 282

  Authors: Zaher K., Jawad A., Ali I.

• Exosomes biological significance: A concise review

  Citation: 269

  Authors: Rose M.

• Hepcidin, A New Iron Regulatory Peptide

  Citation: 254

  Authors: Gaël, Lydie, Myriam, Carole, Axel, Sophie

• The Human Nramp2 Gene: Characterization of the Gene Structure, Alternative Splicing, Promoter Region and Polymorphisms

  Citation: 253

  Authors: Pauline L., Terri, Carol, Carol, Ernest

---